UC Berkeley
PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics
In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.
For Research
An editorial in Nature argues that CRISPR patent holders could do more to ensure gene editing tools are available to researchers.
New Borg Collective
Science reports that researchers have uncovered extrachromosomal elements they have dubbed Borgs after the Star Trek aliens.
NFTs of Nobel-Linked Work
The University of California, Berkeley, is offering non-fungible tokens for patent disclosures for Nobel Prize-winning work.
The company's DETECTR disease detection platform will be used to help develop the technology and optimize the CRISPR enzymes used in the point-of-care device.